Testsealabs COVID-19 Antigen Rapid Test can effectively cover coronavirus Omicron (B.1.1529) variant strain

Share on facebook
Share on twitter
Share on linkedin

At present, our company conducts detailed comparison and analysis based on the nucleic acid sequence of the mutation site of the Omicron mutant strain published by the GISAID database and the recognition epitope of the specific anti-N protein antibody used in our Coronavirus antigen rapid test products. The analysis results showed that the mutation site of the Omicron mutant strain did not affect the antigen detection of coronavirus antigen rapid detection reagent developed, produced and sold by our company. Our company’s Testsealabs COVID-19 Antigen Rapid Test can effectively cover the new coronavirus Omicron (B.1.1529) mutant strain.

However, since it is currently impossible to obtain specimens for verification, subsequent verification tests are required in the laboratory. Our company has verified the detection performance of coronavirus antigen rapid test developed by our company by using methods such as clinical sample detection and analysis, biological mutation sequence analysis, and artificially simulated mutant strain sample analysis.
Up to now, it has been evaluated and verified that Testsealabs COVID-19 Antigen Rapid Test developed by our company can effectively detect the following mutant strains: Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B. .1.617.2), Lambda (C.37), Eta (B.1.525), Iota (B.1.526), Mu (B.1.621), Kappa (B.1.617.1), Theta, C.36.3, C .1.2, B.1.1.318, B.1.617.3, Zeta, AV.1, A.23.1, Epsilon and other follow-ups. Our company will continue to track and monitor the mutation of coronavirus, and will follow up the latest information in time to ensure that I The rapid detection reagents for coronavirus antigen produced and sold by the company can cover all major coronavirus mutant strains and avoid the occurrence of missed detection. Thank you for your attention.
In the future, our company will continue to track and monitor the mutation of coronavirus, and will follow up with the latest information in time to ensure that the rapid detection reagents for coronavirus antigen produced and sold by our company can cover all major coronavirus mutant strains and avoid the occurrence of missed detections. thanks for your attention.